Brief: Adicet Bio Q4 loss per share USD 0.72
15/03/2023 20:02
Mar 15 (Reuters) - Adicet Bio Q4 net income USD -29.875 million. * Q4 operating expenses USD 31.565 million * Q4 EPS USD -0.72
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary